IDEXX Laboratories Inc. has announced the launch of the Catalyst® Cortisol Test, designed to measure real-time quantitative cortisol concentrations in dogs. This test aids in diagnosing Addison's disease and managing Cushing's syndrome, marking the third expansion of the Catalyst platform within a year. The Catalyst Cortisol Test is integrated with IDEXX Vetlab® Station and VetConnect® PLUS, providing real-time interpretive guidance during patient visits. The new test offers a load-and-go workflow, allowing it to run alone or with additional chemistry tests from a single sample. This feature is intended to improve efficiency by reducing sample preparation time and ensuring consistent results. The Catalyst Cortisol Test will be available in the U.S. and Canada by the end of July 2025, with an international rollout planned for the third quarter of 2025.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。